Our data indicate that both CYP4A11, CYP4A22, and CYP4F2 mRNA levels increase in steatosis (Figures 4A, B, 5A) while both CYP4A11 and CYP4A22 increase in steatohepatitis. This evidence concerns the gene CYP4A22 and steatosis.